General Psychiatry
RSS
Lurasidone vs Quetiapine in Bipolar Depression
Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.
Mitochondrial Modulators and Bipolar Depression
Simon M. Dosovitz, MD. Dr. Dosovitz has no financial relationships with companies related to this material.
How to Identify and Treat Prodromal Symptoms of Bipolar Disorder and Schizophrenia
José S. Sanchez-Cruz, MD. Chief Resident, Department of Psychiatry, NYU Langone Health, New York. Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.
Dr. Sanchez-Cruz and Dr. Aiken have no financial relationships with companies related to this material.
A Disease-Modifying Approach to Mood Conditions
S. Nassir Ghaemi, MD, MPH.
Professor of Psychiatry and Director of the Psychopharmacology Consultation Clinic at Tufts Medical Center.
Dr. Ghaemi has no financial relationships with companies related to this material.
The Antipsychotic-Stimulant Combo
Avneet Soin, MD. Psychiatry resident, NYU Grossman School of Medicine. Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York.
Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.
Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York
Dr. Soin, Dr. Anbarasan, and Dr. Aiken have no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
